Funding · Company
Tasca Therapeutics Corp
Cambridge, MABiotech & Pharma
Tasca Therapeutics Corp of Cambridge, MA has disclosed $48M across 1 Form D offering filed with the SEC on Dec 1, 2025.
$48M
Total disclosed
1
Form D offering
2021
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$48M
Form D · Dec 1, 2025 ↗
Q4 2025
· 1 amendment, first filed Nov 29, 2024
· target $70M
Filing details
HeadquartersCambridge, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2021SEC CIK0002046762Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →